Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We present the design, synthesis and biological activity of a new series of substituted 3-(2-(1H-indol-1-yl)ethyl)-1H-indoles and 1,2-di(1H-indol-1-yl)alkanes as selective inhibitors of CDK4/cyclin D1. The compounds were designed to explore the relationship between the connection mode of the indolyl moieties and their CDK inhibitory activities. We found all the above-mentioned designed compounds to be selective inhibitors of CDK4/cyclin D1 compared to the closely related CDK2/cyclin A, with IC(50) for the best compounds 10m and 13a being 39 and 37microm, respectively.

Original publication

DOI

10.1016/j.bmc.2009.06.070

Type

Journal article

Journal

Bioorg Med Chem

Publication Date

15/08/2009

Volume

17

Pages

6073 - 6084

Keywords

Binding Sites, Computer Simulation, Cyclin A, Cyclin D1, Cyclin-Dependent Kinase 2, Cyclin-Dependent Kinase 4, Drug Design, Humans, Indoles, Protein Kinase Inhibitors